Pharmacovigilance

Transforming Pharmacovilgilance

At EVERSANA, we elevate pharmacovigilance from a regulatory obligation to a strategic advantage. Powered by GenAI and guided by industry experts, our integrated Medical Information–Pharmacovigilance solutions provide real-time insights that strengthen drug safety and enable faster, smarter decisions.

We don’t just automate—we innovate. Our advanced technology layer brings predictive signal detection, proactive risk modeling, and GenAI-assisted co-authoring to the forefront, transforming safety data into actionable intelligence that drives better patient outcomes.

Three Strategic Pillars that Drive Our Approach

Integrated MI-PV Ecosystem

Break down silos by unifying Medical Information and Pharmacovigilance into a seamless workflow. From inquiry intake to signal detection, gain total visibility and accelerate decision-making.

PV Experts-Led GenAI

Leverage AI that enhances, not replaces, human expertise. Our GenAI solutions assist in narrative generation, literature screening and signal detection, all under the supervision of seasoned PV professionals.

Proven Inspection Success

Achieve zero regulatory findings through agency-specific inspection preparation, comprehensive gap analysis and tailored remediation strategies. We prepare you not just for inspections, but for excellence.

Market Complexities Call for an Integrated Approach to Pharmacovigilance

The increasingly complex pharmaceutical market presents significant challenges for manufacturers executing pharmacovigilance activities:

Vendor Overload: Managing multiple vendors across various pharmacovigilance functions, such as literature monitoring, case processing, aggregate reports, signal detection, and regulatory reporting, can lead to fragmented operations, inconsistent data quality, and increased compliance risks. This fragmentation hampers efficiency and may compromise patient safety.
Surmounting Cost, Quality, and Timeline Challenges: Adverse event surges, global expansion, shifting regulations, and accelerated timelines raise operational costs and quality concerns.

EVERSANA’s Integrated Pharmacovigilance Solution offers a streamlined, cost-effective approach that ensures compliance by delivering fully processed adverse event cases and effective use of your product throughout its life cycle.

AI Meets Human Expertise

Our pharmacovigilance solution seamlessly integrates expert human oversight with advanced AI technologies to deliver high-quality, regulation-compliant adverse event data. By leveraging intelligent automation, we significantly accelerate case processing timelines without compromising data integrity. This empowers Marketing Authorization Holders (MAHs) to proactively manage safety risks, meet global regulatory demands, and make confident, data-driven decisions.

EVERSANA ORCHESTRATE™ PV

An AI-powered, expert-led digital solution that tackles critical challenges in literature monitoring and aggregate authoring—delivering speed, precision, scalability, and cost efficiency.

Learn More

Modular Service Offerings

Business Process Solutioning

Redesign PV operations with scalability, automation and compliance at the core.

Third-Party Audits & MAH Inspection Readiness

Conducted by experienced GVP QA auditors to ensure preparedness.

QPPV & LPPV Services

Global reach with local compliance, including 24/7 access and PSMF maintenance.

SDEA Management

Contract drafting, partner negotiation and ongoing compliance monitoring.

Health Hazard Evaluation Reports

Structured templates with regulatory alignment for recall decisions.

Label Management and PLLR

Updates aligned with new safety signals or periodic reporting.

New Article

What you need to know about emerging regulations and their implications.

Read Now